Has Jesus Rame, MD received payments from drug or device companies?

Yes. Drug and device makers reported $376,825 in general payments to Jesus Rame, MD across 651 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jesus Rame, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jesus Rame, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jesus Rame, MD

Advanced Heart Failure and Transplant Cardiology · Philadelphia, PANPI 1417914953

Payments from drug & device makers

$376,825in general payments, 2019–2025

Across 651 payments — averaging $578.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merck$143K
E.r. Squibb & Sons, L.L.C.$84K
Lexicon Pharmaceuticals, Inc.$42K
Abbott$36K
Endotronix, Inc.$22K
Boston Scientific$19K
plus $30K from 39 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merck	112	$142,520
E.r. Squibb & Sons, L.L.C.	91	$84,394
Lexicon Pharmaceuticals, Inc.	32	$42,491
Abbott	130	$35,754
Endotronix, Inc.	4	$22,048
Boston Scientific	14	$19,463
Fresenius USA Marketing, Inc.	16	$10,750
Bayer	7	$6,904
Medtronic(2 entities)	7	$2,120
Abiomed	27	$1,873
Actelion Pharmaceuticals US, Inc.	36	$1,265
Impulse Dynamics (USA) Inc.	13	$869
United Therapeutics Corporation	18	$861
Boehringer Ingelheim	22	$743
Baxter Healthcare	21	$718
Daxor Corporation	6	$531
AstraZeneca	10	$497
ZOLL Respicardia, Inc.	2	$343
Bristol Myers Squibb	1	$300
Ancora Heart, Inc.	2	$286
Amgen	9	$230
Pfizer	11	$209
Novartis	12	$196
Cvrx, Inc.	4	$192
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	6	$191
Novo Nordisk	2	$142
Alnylam Pharmaceuticals Inc.	5	$117
Heartflow, Inc.	4	$109
Nuwellis, Inc.	3	$90
Picard Medical Inc.	1	$83
Johnson & Johnson	4	$76
Philips North America LLC	4	$74
One Lambda, Inc.	1	$65
Scpharmaceuticals Inc.	2	$53
Kiniksa Pharmaceuticals, Ltd.	2	$45
Atricure, Inc.	1	$27
GE HealthCare	1	$25
Daiichi Sankyo Inc.	1	$25
Irhythm Technologies, Inc.	1	$23
Sandoz	1	$22
Bridgebio Pharma, Inc.	1	$21
Esperion Therapeutics, Inc.	1	$20
KCI USA, Inc.	1	$20
Edwards Lifesciences	1	$19
Akcea Therapeutics, Inc.	1	$19

How this compares

$376,825 in reported general payments places this provider in the 85th percentile of 96 advanced heart failure and transplant cardiology providers in Pennsylvania.

See all advanced heart failure and transplant cardiology providers in Pennsylvania →

Medicare billing

Part B allowed, 2024

$70,710

Medicare patients

217

Services billed

781

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other advanced heart failure and transplant cardiology in Philadelphia

Anjali OwensPhiladelphia$1.7M
Kenneth MarguliesPhiladelphia$1.7M
Anjali VaidyaPhiladelphia$805K
Ileana PinaPhiladelphia$396K
Jeremy MazurekPhiladelphia$371K
Joyce WaldPhiladelphia$265K
Lee GoldbergPhiladelphia$197K
Monique TannaPhiladelphia$181K
Stuart PrennerPhiladelphia$172K
Behnam BozorgniaPhiladelphia$107K

See the full list for Pennsylvania →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →